| Name | YIAD-0205 |
|---|
| Description | YIAD-0205 is an orally available Aβ(1?42) aggregation inhibitor. YIAD-0205 demonstrated in vivo efficacy in an AD transgenic mouse model with five familial AD mutations (5XFAD)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H16Br2ClN3 |
|---|---|
| Molecular Weight | 565.69 |